ENDOSCOPIC HEMOSTASIS WITH FIBRIN GLUE IN PEPTIC-ULCER HEMORRHAGE - ECONOMIC-ASPECTS

Endoscopic injections of fibrin glue for the treatment of gastroduoden al ulcer hemorrhage have been increasingly used instead of sclerosing agents since 1987. Sclerosants have the drawback that they themselves have tissue-destroying or rather ulcerogenic effects. A difficult form of administration and a relatively high price are set against the goo d biological properties of the fibrin glue, In a randomized study comp aring fibrin glue with polidocanol there was a statistically significa nt lower rebleeding rate in the fibrin group, The data of this study w ere analysed with regard to economic aspects, They showed an improved cost-benefit and cost-effectiveness ratio of the fibrin glue compared with polidocanol.